Gold Mining News – Lifestyle
Home
Sample Page
Author:
HAEMONETICS CORPORATION
Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
May 7, 2026
Haemonetics to Present at Bank of America 2026 Healthcare Conference
May 5, 2026
New Study Highlights Safety and Efficacy Profile of Haemonetics’ VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures
April 24, 2026
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026
April 1, 2026
Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System
March 30, 2026